Back
Day Range
$19.53
$20.33
52-Week Range
$18.41
$42.37
Volume
2,031,847
50D / 200D Avg
$22.84
/
$29.64
Prev Close
$19.87
Price History
Financial Trends
Peer Comparison
vs Healthcare sector median (626 peers)
| Metric | Stock | Sector Median |
|---|---|---|
| P/E | -3.4 | 0.4 |
| P/B | — | 2.9 |
| ROE % | -656.0 | 3.8 |
| Net Margin % | -85.4 | 3.9 |
| Rev Growth 5Y % | 17.6 | 10.0 |
| D/E | — | 0.2 |
Analyst Price Target
Hold
$49.90
+146.2%
Low: $34.00
High: $63.00
Forward EPS
-$4.36
Est. Revenue
750 M
Earnings Estimates
| Period | EPS Est. | Revenue Est. | Analysts |
|---|---|---|---|
| FY2030 |
$5.58
$4.11 – $7.98
|
2.2 B | 4 |
| FY2029 |
$3.22
$2.37 – $4.60
|
1.7 B | 4 |
| FY2028 |
$1.30
-$1.30 – $5.44
|
1.4 B | 11 |
Key Takeaways
Revenue grew 17.64% annually over 5 years — strong growth
Negative free cash flow of -472.00M
PEG of 0.54 suggests growth is underpriced
Capital efficient — spends only 0.89% of revenue on capex
Growth
Revenue Growth (5Y)
17.64%
Revenue (1Y)20.13%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Quality
Return on Equity
-656.03%
ROIC-33.55%
Net Margin-85.44%
Op. Margin-79.49%
Safety
Debt / Equity
N/A
Current Ratio2.48
Interest Coverage-8.63
Valuation
P/E Ratio
-3.41
P/B RatioN/A
EV/EBITDAN/A
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 20.13% | Revenue Growth (3Y) | 24.49% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 17.64% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 673.00M | Net Income (TTM) | -575.00M |
| ROE | -656.03% | ROA | -37.53% |
| Gross Margin | 83.80% | Operating Margin | -79.49% |
| Net Margin | -85.44% | Free Cash Flow (TTM) | -472.00M |
| ROIC | -33.55% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | N/A | Current Ratio | 2.48 |
| Interest Coverage | -8.63 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | -3.41 | P/B Ratio | N/A |
| P/S Ratio | 2.91 | PEG Ratio | 0.54 |
| EV/EBITDA | N/A | Dividend Yield | 0.00% |
| Market Cap | 1.96B | Enterprise Value | 2.80B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 673.00M | 560.23M | 434.25M | 363.33M | 351.41M |
| Net Income | -575.00M | -569.18M | -606.64M | -707.42M | -454.03M |
| EPS (Diluted) | -5.83 | -6.29 | -8.25 | -10.12 | -6.70 |
| Gross Profit | 564.00M | 483.50M | 389.04M | 335.01M | 335.40M |
| Operating Income | -535.00M | -535.97M | -569.21M | -648.92M | -381.74M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 1.53B | 1.50B | 1.49B | 1.55B | 1.52B |
| Total Liabilities | 1.61B | 1.24B | 1.22B | 1.19B | 599.84M |
| Shareholders' Equity | -80.00M | 255.30M | 275.41M | 352.49M | 922.56M |
| Total Debt | 1.28B | 40.34M | 43.17M | 31.59M | 41.97M |
| Cash & Equivalents | 434.00M | 173.73M | 213.58M | 132.94M | 307.58M |
| Current Assets | 951.00M | 817.12M | 732.18M | 883.90M | 856.60M |
| Current Liabilities | 384.00M | 344.15M | 280.44M | 261.21M | 181.37M |